BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 12586300)

  • 1. HFE mutations and chronic hepatitis C: H63D and C282Y heterozygosity are independent risk factors for liver fibrosis and cirrhosis.
    Erhardt A; Maschner-Olberg A; Mellenthin C; Kappert G; Adams O; Donner A; Willers R; Niederau C; Häussinger D
    J Hepatol; 2003 Mar; 38(3):335-42. PubMed ID: 12586300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common heterozygous hemochromatosis gene mutations are risk factors for inflammation and fibrosis in chronic hepatitis C.
    Geier A; Reugels M; Weiskirchen R; Wasmuth HE; Dietrich CG; Siewert E; Gartung C; Lorenzen J; Bosserhoff AK; Brügmann M; Gressner AM; Matern S; Lammert F
    Liver Int; 2004 Aug; 24(4):285-94. PubMed ID: 15287851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemochromatosis and transferrin receptor gene polymorphisms in chronic hepatitis C: impact on iron status, liver injury and HCV genotype.
    Gehrke SG; Stremmel W; Mathes I; Riedel HD; Bents K; Kallinowski B
    J Mol Med (Berl); 2003 Dec; 81(12):780-7. PubMed ID: 14557859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severity.
    Chitturi S; Weltman M; Farrell GC; McDonald D; Kench J; Liddle C; Samarasinghe D; Lin R; Abeygunasekera S; George J
    Hepatology; 2002 Jul; 36(1):142-9. PubMed ID: 12085358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and clinical implications of HFE gene mutations (C282Y and H63D) in patients with chronic hepatitis B and C in Taiwan.
    Mah YH; Kao JH; Liu CJ; Chen CL; Chen PJ; Lai MY; Chen DS
    Liver Int; 2005 Apr; 25(2):214-9. PubMed ID: 15780041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular analysis of A1AT (S and Z) and HFE (C282Y and H63D) gene mutations in Egyptian cases with HCV liver cirrhosis.
    Settin A; El-Bendary M; Abo-Al-Kassem R; El Baz R
    J Gastrointestin Liver Dis; 2006 Jun; 15(2):131-5. PubMed ID: 16802007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HFE gene mutations, hepatic iron content, and histological severity in hepatitis C virus-induced chronic hepatitis.
    Ladero JM; Ropero P; Ortega L; Taxonera C; González FA; López-Alonso G; Briceño O; Rodríguez-Agulló JL; González L; Villegas A; Díaz-Rubio M
    Rev Esp Enferm Dig; 2003 Dec; 95(12):829-36. PubMed ID: 14972004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of HFE gene C282Y and H63D mutations with liver cirrhosis in the Lithuanian population.
    Juzėnas S; Kupčinskas J; Valantienė I; Šumskienė J; Petrenkienė V; Kondrackienė J; Kučinskas L; Kiudelis G; Skiecevičienė J; Kupčinskas L
    Medicina (Kaunas); 2016; 52(5):269-275. PubMed ID: 27816425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of association of primary iron overload and common HFE gene mutations with liver cirrhosis in adult Indian population.
    Jain S; Agarwal S; Tamhankar P; Verma P; Choudhuri G
    Indian J Gastroenterol; 2011 Jul; 30(4):161-5. PubMed ID: 21822737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HFE mutations, iron deficiency and overload in 10,500 blood donors.
    Jackson HA; Carter K; Darke C; Guttridge MG; Ravine D; Hutton RD; Napier JA; Worwood M
    Br J Haematol; 2001 Aug; 114(2):474-84. PubMed ID: 11529872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in hepatic phenotype between hemochromatosis patients with HFE C282Y homozygosity and other HFE genotypes.
    Cheng R; Barton JC; Morrison ED; Phatak PD; Krawitt EL; Gordon SC; Kowdley KV
    J Clin Gastroenterol; 2009 Jul; 43(6):569-73. PubMed ID: 19359997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C.
    Smith BC; Gorve J; Guzail MA; Day CP; Daly AK; Burt AD; Bassendine MF
    Hepatology; 1998 Jun; 27(6):1695-9. PubMed ID: 9620344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence of HFE C282Y gene mutation is increased in Spanish patients with porphyria cutanea tarda without hepatitis C virus infection.
    Toll A; Celis R; Ozalla MD; Bruguera M; Herrero C; Ercilla MG
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1201-6. PubMed ID: 17062032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mild iron overload in patients carrying the HFE S65C gene mutation: a retrospective study in patients with suspected iron overload and healthy controls.
    Holmström P; Marmur J; Eggertsen G; Gåfvels M; Stål P
    Gut; 2002 Nov; 51(5):723-30. PubMed ID: 12377814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of HFE mutations and relation to serum iron status in patients with chronic hepatitis C and patients with nonalcoholic fatty liver disease in Taiwan.
    Lin TJ; Lin CL; Wang CS; Liu SO; Liao LY
    World J Gastroenterol; 2005 Jul; 11(25):3905-8. PubMed ID: 15991291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iron overload and HFE gene mutations in Czech patients with chronic liver diseases.
    Dostalikova-Cimburova M; Kratka K; Stransky J; Putova I; Cieslarova B; Horak J
    Dis Markers; 2012; 32(1):65-72. PubMed ID: 22297603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HFE C282Y heterozygosity in hepatocellular carcinoma: evidence for an increased prevalence.
    Hellerbrand C; Pöppl A; Hartmann A; Schölmerich J; Lock G
    Clin Gastroenterol Hepatol; 2003 Jul; 1(4):279-84. PubMed ID: 15017669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between heterozygosity for HFE gene mutations and hepatitis viruses in hepatocellular carcinoma.
    Fracanzani AL; Fargion S; Stazi MA; Valenti L; Amoroso P; Cariani E; Sangiovanni A; Tommasini M; Rossini A; Bertelli C; Fatta E; Patriarca V; Brescianini S; Stroffolini T
    Blood Cells Mol Dis; 2005; 35(1):27-32. PubMed ID: 15894495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of mutation of the HFE gene on the progression of chronic viral hepatitis B and C in Moroccan patients.
    Ezzikouri S; Rebbani K; Mostafa A; El Feydi AE; Afifi R; Brahim I; Kitab B; Benazzouz M; Kandil M; Nadifi S; Pineau P; Benjelloun S
    J Med Virol; 2011 Dec; 83(12):2096-102. PubMed ID: 22012716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations of the HFE gene in patients with hepatocellular carcinoma.
    Cauza E; Peck-Radosavljevic M; Ulrich-Pur H; Datz C; Gschwantler M; Schöniger-Hekele M; Hackl F; Polli C; Rasoul-Rockenschaub S; Müller C; Wrba F; Gangl A; Ferenci P
    Am J Gastroenterol; 2003 Feb; 98(2):442-7. PubMed ID: 12591066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.